The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2
Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators
红细胞分布宽度对接受择期经皮冠状动脉介入治疗非贫血患者预后的影响
刘新民, 董建增, 刘小慧, 康俊萍, 罗太阳, 关杨, 戴天医, 张崟, 白融, 杜昕, 马长生
Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis
Guo XY, Li N, Du X, Bai R, Yu RH, Long DY, Tang RB, Sang CH, Jiang CX, Ning M, Li SN, Liu N, Dong JZ, Ma CS
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge
Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study
Xia SJ, Du X, Li C, Wu JH, Tang RB, Chang SS, Guo XY, Yu RH, Long DY, Bai R, Liu N, Sang CH, Li SN, Liu XH, Pan JH, Dong JZ, Lip GY, Ma CS
Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation
Wang ZZ, Du X, Wang W, Tang RB, Luo JG, Li C, Chang SS, Liu XH, Sang CH, Yu RH, Long DY, Wu JH, Bai R, Liu N, Ruan YF, Dong JZ, Ma CS
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY; GLORIA-AF Investigators
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S
Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study
Chang SS, Dong JZ, Ma CS, Du X, Wu JH, Tang RB, Xia SJ, Guo XY, Yu RH, Long DY, Bai R, Liu N, Sang CH, Jiang CX, Liu XH, Pan JH, Lip GY
Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry
Song J, Sheng CS, Huang QF, Li LH, Ma CS, Guo XH, Ji LN, Wang JG; ATTEND Investigators
Rationale and design of the Chinese Atrial Fibrillation Registry Study
Du X, Ma C, Wu J, Li S, Ning M, Tang R, Guo X, Long D, Yu R, Sang C, Jiang C, Zhang T, Pan J, Liu X, Dong J, Lip GY; CAFR Investigators
Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation
Yao Y, Yao W, Bai R, Lu ZH, Tang RB, Long DY, Jiang CX, Sang CH, Zhang JQ, Yu RH, Du X, Liu XH, Dong JZ, Ma CS
Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
Kong Y, Du X, Tang RB, Zhang T, Guo XY, Wu JH, Xia SJ, Ma CS
Reversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation
Wu JH, Li HK, Couri DM, Araoz PA, Lee YH, Ma CS, Packer DL, Cha YM
Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies
Li X, Wen SN, Li SN, Bai R, Liu N, Feng L, Ruan YF, Du X, Dong JZ, Ma CS
Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review
Bai Y, Chen H, Yang Y, Li L, Liu XY, Shi XB, Ma CS
Acute coronary syndrome in the Asia-Pacific region
Chan MY, Du X, Eccleston D, Ma C, Mohanan PP, Ogita M, Shyu KG, Yan BP, Jeong YH
QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Wen SN, Liu N, Li SN, Wu XY, Salim M, Kang JP, Ning M, Wu JH, Ruan YF, Yu RH, Long DY, Tang RB, Sang CH, Jiang CX, Bai R, Du X, Dong JZ, Liu XH, Ma CS
Pouched mitral isthmus is associated with incomplete linear block in atrial fibrillation patients with mechanical mitral valve replacement
Deng WN, Chen KE, Bai R, Zhang ZJ, Li SN, Wen ZY, Zhang C, Yu RH, Long DY, Tang RB, Sang CH, Liu N, Guo XY, Wu XY, Nie JG, Du X, Dong JZ, Ma CS
Relationship between red blood cell distribution width and intermediate-term mortality in elderly patients after percutaneous coronary intervention
Liu XM, Ma CS, Liu XH, Du X, Kang JP, Zhang Y, Wu JH
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: two-year results from a prospective patient-level pooled analysis of TARGET trials
Gao Z, Zhang R, Xu B, Yang Y, Ma C, Li H, Chen S, Han Y, Yuan Z, Lansky AJ, Guan C, Leon MB, Gao R; TARGET Investigators
Catheter ablation of atrial fibrillation in patients with rheumatoid arthritis
Wen SN, Liu N, Li SN, Salim M, Yan Q, Wu XY, Wang Y, Kang JP, Ning M, Wu JH, Ruan YF, Yu RH, Long DY, Tang RB, Sang CH, Jiang CX, Bai R, Hu R, Du X, Dong JZ, Liu XH, Ma CS
Catheter ablation of atrial fibrillation in patients with atrial septal defect: long-term follow-up results
Nie JG, Dong JZ, Salim M, Li SN, Wu XY, Chen YW, Bai R, Liu N, Du X, Ma CS
Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation
Lin T, Bai R, Chen YW, Yu RH, Tang RB, Sang CH, Li SN, Ma CS, Dong JZ
Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation
Tang RB, Dong JZ, Yan XL, Du X, Kang JP, Wu JH, Yu RH, Long DY, Ning M, Sang CH, Jiang CX, Salim M, Bai R, Yao Y, Ma CS
HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation
Lu ZH, Liu N, Bai R, Yao Y, Li SN, Yu RH, Sang CH, Tang RB, Long DY, Du X, Dong JZ, Ma CS
Electroanatomical mapping of the right atrium during atrial tachycardia originating from right superior pulmonary vein: additional insights on differential diagnosis
Long DY, Salim M, Dong JZ, Sang CH, Jiang CX, Tang RB, Li SN, Yu RH, Yao Y, Ning M, Sheng C
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
Cappato R, Ezekowitz MD, Klein AL, Camm AJ, Ma CS, Le Heuzey JY, Talajic M, Scanavacca M, Vardas PE, Kirchhof P, Hemmrich M, Lanius V, Meng IL, Wildgoose P, van Eickels M, Hohnloser SH; X-VeRT Investigators
Long-term results of single-procedure catheter ablation for atrial fibrillationin pre- and post-menopausal women
Lin T, Du X, Bai R, Chen YW, Yu RH, Long DY, Tang RB, Sang CH, Li SN, Ma CS, Dong JZ
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation
Naccarelli GV, Cappato R, Hohnloser SH, Marchlinski FE, Wilber DJ, Xiang J, Ma C, Hess S, Davies DW, Fields LE, Natale A; VENTURE-AF Investigators